Tolerability of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs: A study of 216 patients and literature review

International Archives of Allergy and Immunology

Volumn 132, Issue 1, 2003, Pages 82-86

  Perrone, Maria Rosaria ^a   Artesani, Maria Cristina ^a   Viola, Marinella ^a   Gaeta, Francesco ^a   Caringi, Mario ^a   Quaratino, Donato ^b   Romano, Antonino ^a,c,d  

^a CATHOLIC UNIVERSITY   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

^d Unità di Allergologia   (Italy)

Author keywords

Challenges; Hypersensitivity; Nonsteroidal anti inflammatory drugs; Rofecoxib

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; ISOENZYME; KETOPROFEN; KETOROLAC; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORAMIDOPYRINE; PARACETAMOL; PIROXICAM; PLACEBO; PROSTAGLANDIN SYNTHASE; ROFECOXIB;

ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DYSPNEA; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT DISEASE; RHINOCONJUNCTIVITIS; SINGLE BLIND PROCEDURE; SKIN MANIFESTATION; URTICARIA; WHEEZING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DRUG HYPERSENSITIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERSENSITIVITY; LACTONES; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; SULFONES;

EID: 0141889582     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073268     Document Type: Article

References (36)

1. Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E, Cocci A, Moretti U, Velo G, Leone R: Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999;48:839-846.
2. Namazy JA, Simon RA: Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002;89:542-550.
3. Stevenson DD: Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984;74:617-622.
4. Szczeklik A: Adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann Allergy 1987;59:113-118.
5. Czerniawska-Mysik G, Szczeklik A: Idiosyncrasy to pyrazolone drugs. Allergy 1981;36:381-384.
6. Kowalski ML, Woszczek G, Bienkiewicz B, Mis M: Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin Exp Allergy 1998;28:1153-1158.
7. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-235.
8. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975;1:67-69.
9. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G: Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977;60:276-284.
10. Carmona MJ, Blanca M, Garcia A, Fernandez S, Burgos F, Miranda A, Vega JM, Garcia J: Intolerance to piroxicam in patients with adverse reactions to nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 1992;90:873-879.
11. Szczeklik A, Stevenson DD: Aspirin-induced asthma: Advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13.
12. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-2696.
13. Vane JR: Towards a better aspirin. Nat New Biol 1994;367:215-216.
14. Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson AW, Forrest MJ, Gauthier JY, Gordon R, Gresser M, Guay J, Kargman S, Kennedy B, Leblanc Y, Leger S, Mancini J, O'Neil GP, Ouellet M, Patrick D, Percival MD, Perrier H, Prasit P, Rodger I: Rofecoxib: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther 1999;290:551-560.
15. Enrique E, Cisteró-Bahíma A, San Miguel-Moncín MM, Alonso R: Rofecoxib should be tried in NSAID hypersensitivity. Allergy 2000;55:1090.
16. Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M: Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31:219-225.
17. Zollner TM, Ahlbach S, Kaufmann R, Boehncke WH: Tolerability of a selective COX-2 inhibitor (rofecoxib) in patients with intolerance reactions to nonsteroidal anti-inflammatory agents. Dtsch Med Wochenschr 2001;126:386-388.
18. Stevenson DD, Simon RA: Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.
19. Hinrichs R, Ritzkowsky A, Hunzelmann N, Krieg T, Scharffetter-Kochanek K: Rofecoxib as an alternative in Aspirin hypersensitivity. Allergy 2001;56:789.
20. Sánchez Borges M, Capriles-Hulett A, Caballero-Fonseca F, Pérez CR: Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001;87:201-204.
21. Asero R: Tolerability of rofecoxib. Allergy 2001;56:916-917.
22. Berges-Gimeno MP, Camacho-Garrido E, Garcia-Driguez RM, Alfaya T, Martin Garcia C, Hinojosa M: Rofecoxib safe in NSAID hypersensitivity. Allergy 2001;56:1017-1018.
23. Nettis E, Di Paola R, Ferrannini A, Tursi A: Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002;88:331-334.
24. Pacor ML, Di Lorenzo G, Biasi D, Barbagallo M, Corrocher R: Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or nonsteroidal anti-inflammatory drugs. Clin Exp Allergy 2002;32:397-400.
25. Martin-Garcia C, Hinojosa M, Berges P, Camacho E, Garcia-Rodriguez R, Alfaya T, Iscar A: Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest 2002;121:1812-1817.
26. Quiralte J, de San Pedro BS, Florido JJF: Safety of selective COX-2 inhibitor rofecoxib in patients with NSAIDs-induced cutaneous reactions. Ann Allergy Asthma Immunol 2002;89:63-66.
27. Valero A, Baltasa M, Enrique E, Pau L, Dordal MT, Cistero A, Marti E, Picado C: NSAID-sensitive patients tolerate rofecoxib. Allergy 2002;57:1214-1215.
28. Johansson SGO, Hourihane JO'B, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hagen-Hamsten M, Wüthrich B: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824.
29. Papa G, Romano A, Del Bono A, Quaratino D, Di Fonso M, Pocobelli D, Giuffreda F, Venuti A: Floctafenine: a valid alternative in patients with adverse reactions to non steroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 1997;78:74-78.
30. Quaratino D, Romano A, Papa G, Di Fonso M, Giuffreda F, D'Ambrosio FP, Venuti A: Long-term tolerability of nimesulide and acetaminophen in nonsteroidal anti-inflammatory drug-intolerant patients. Ann Allergy Asthma Immunol 1997;79:47-50.
31. Quaratino D, Romano A, Di Fonso M, Papa G, Perrone MR, Purello D'Ambrosio F, Venuti A: Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2000;84:613-617.
32. Ispano M, Fontana A, Scibilia J, Ortolani C: Oral challenge with alternative nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen in patients intolerant to these agents. Drugs 1993;46(suppl 1):253-256.
33. Passalacqua G, Milanese M, Mincarini M, Ciprandi G, Guerra L, Scordamaglia A, Canonica GW: Single-dose oral tolerance test with alternative compounds for the management of adverse reactions to drugs. Int Arch Allergy Immunol 2002;129:242-247.
34. SIAIC Memorandum on drugs allergy/intolerance diagnosis. Ital J Allergy Clin Immunol 1998;8:568-595.
35. Delaney JC: The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin Allergy 1976;6:177-181.
36. Falliers CJ: Acetaminophen and aspirin challenges in subgroups of asthmatics. J Asthma 1983;20:39-49.